MedChemComm p. 2093 - 2099 (2017)
Update date:2022-08-03
Topics:
Duclos, Franck
Abell, Lynn M.
Harden, David G.
Pike, Kristen
Nowak, Kimberly
Locke, Gregory A.
Duke, Gerald J.
Liu, Xiaoqin
Fernando, Gayani
Shaw, Scott A.
Vokits, Benjamin P.
Wurtz, Nicholas R.
Viet, Andrew
Valente, Meriah N.
Stachura, Sylwia
Sleph, Paul
Khan, Javed A.
Gao, Ji
Dongre, Ashok R.
Zhao, Lei
Wexler, Ruth R.
Gordon, David A.
Kick, Ellen K.
Myeloperoxidase, a mammalian peroxidase involved in the immune system as an anti-microbial first responder, can produce hypochlorous acid in response to invading pathogens. Myeloperoxidase has been implicated in several chronic pathological diseases due to the chronic production of hypochlorous acid, as well as other reactive radical species. A high throughput screen and triaging protocol was developed to identify a reversible inhibitor of myeloperoxidase toward the potential treatment of chronic diseases such as atherosclerosis. The identification and characterization of a reversible myeloperoxidase inhibitor, 7-(benzyloxy)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine is described.
View MoreContact:+86-535-8888888
Address:No.161 Haishi Rd.
Contact:86-311-67265101
Address:203 Lianmeng Road, Qiaoxi District
Yangling Ciyuan biotech Co., Ltd.
Contact:86-15802970736
Address:2-1804, International Park Mansion, No.2, South Fengdeng Road, Lianhu District
Lianyungang Ningkang Chemical Co., Ltd
Contact:.+86-518-88588008
Address:http://www.chemnk.com
Contact:+86-021-6989-5597
Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Doi:10.1002/asia.201301245
(2014)Doi:10.1021/co4001452
(2014)Doi:10.1021/ja00403a069
(1981)Doi:10.1002/jlcr.2580340804
(1994)Doi:10.1016/j.molstruc.2011.09.051
(2011)Doi:10.1016/S0957-4166(00)86199-6
(1994)